Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 32Colonic Neoplasms 8Rectal Neoplasms 7Neoplasm Metastasis 5Stomach Neoplasms 3Pancreatic Neoplasms 3Gallbladder Neoplasms 3Cholangiocarcinoma 3Neutropenia 2Bile Duct Neoplasms 2Adenocarcinoma 2mCRC 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Neoplasms 1Nasopharyngeal Carcinoma 1Microsatellite-stable Colorectal Cancer 1Lung Neoplasms 1High-grade Extra Pulmonary Neuroendocrine Cancer 1Gastric Cancer Adenocarcinoma Metastatic 1First-line Treatment 1Esophageal Squamous Cell Carcinoma 1EFS 1Dihydropyrimidine Dehydrogenase Deficiency 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1

Interventions

Gemcitabine 58Cisplatin 32Oxaliplatin 28Fluorouracil 21lenvatinib 19durvalumab 18Capecitabine 17Leucovorin 15tislelizumab 10pembrolizumab 10apatinib 9Floxuridine 8Specimen Handling 7Panitumumab 7Magnetic Resonance Spectroscopy 7Albumin-Bound Paclitaxel 7sintilimab 6pemigatinib 6Radiotherapy 6Irinotecan 6Drug Therapy 6Biopsy 6tremelimumab 5regorafenib 5olaparib 5camrelizumab 5Taxes 5S 1 (combination) 5Nivolumab 5Folfox protocol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Cholangiocarcinoma × trifluridine tipiracil drug combination × Clear all
NCT07146646 2026-02-19

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Case Comprehensive Cancer Center

Phase 2 Recruiting
27 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT03278106 2023-06-28

TAS-102 in Treating Advanced Biliary Tract Cancers

Mayo Clinic

Phase 2 Completed
28 enrolled 12 charts
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT04076761 2022-12-01

MOCHA

Sunnybrook Health Sciences Centre

Phase 2 Terminated
8 enrolled
Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡